Trump’s Plan To Cut Drug Costs: What Changes — And What Doesn’t

Amanda Head asks Dr. McCullough whether Trump’s prescription-drug price reforms could touch vaccine pricing. McCullough says branded drugs will come down under Trump’s negotiation framework — but vaccines likely won’t, because they’re purchased through different channels and protected by long-standing government agreements. He argues that if Americans truly want affordability and fairness, transparency around procurement and liability must be part of the conversation.

Support independent research: mcculloughfnd.org

Credit: Just the News, No Noise — @AmandaHead & @jsolomonReports | Network: @RealAmVoice

#MedicalFreedom